Theravance Biopharma Inc TBPH
Set alert
At close · Sep 23
After hours · Sep 23, 4:00 PM ET
- YTD
- -8.98%
- 1 year
- +58.71%
- Open
- 17.06
- Prev close
- 17.03
- Mkt cap
- 481.42M
- Vol
- 10.02M
- Avg vol
- 194.24K
- EPS
- -1.03
- P/E
- 10.92
- Div yield
- 0.00%
More statistics
- Low
- 17.02
- High
- 17.07
- Forward P/E
- 163.17
- Beta
- 0.25
- Short ratio
- 19.79
- Inst. own
- 96.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 25, 2026
- 50-d avg
- 9.19
- 200-d avg
- 8.90
- 1y target
- 13.20
News
2 weeks ago defenseworld.net
Financial Analysis: Chugai Pharmaceutical (OTCMKTS:CHGCY) & Theravance Biopharma (NASDAQ:TBPH)
Chugai Pharmaceutical (OTCMKTS:CHGCY - Get Free Report) and Theravance Biopharma (NASDAQ: TBPH - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the…
3 weeks ago defenseworld.net
CASI Pharmaceuticals (NASDAQ:CASI) & Theravance Biopharma (NASDAQ:TBPH) Financial Analysis
CASI Pharmaceuticals (NASDAQ: CASI - Get Free Report) and Theravance Biopharma (NASDAQ: TBPH - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will…
4 weeks ago marketbeat.com
Zymeworks Completes Theravance Deal, Adds YUPELRI Cash Flow and Raises 2026 Outlook
Zymeworks NASDAQ: ZYME said it has completed its acquisition of Theravance Biopharma, adding the COPD medicine YUPELRI, an acquired research portfolio, collaboration and royalty economics, Irish tax…
1 month ago defenseworld.net
Theravance Biopharma (NASDAQ:TBPH) versus vTv Therapeutics (NASDAQ:VTVT) Head-To-Head Contrast
vTv Therapeutics (NASDAQ: VTVT - Get Free Report) and Theravance Biopharma (NASDAQ: TBPH - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare…
1 month ago defenseworld.net
Theravance Biopharma (NASDAQ:TBPH) Sees Unusually-High Trading Volume – What’s Next?
Shares of Theravance Biopharma, Inc. (NASDAQ: TBPH - Get Free Report) saw strong trading volume on Tuesday. 769,058 shares were traded during mid-day trading, an increase of 39% from the previous…
1 month ago defenseworld.net
Insider Selling: Theravance Biopharma (NASDAQ:TBPH) SVP Sells $226,737.42 in Stock
Theravance Biopharma, Inc. (NASDAQ: TBPH - Get Free Report) SVP Rhonda Farnum sold 13,314 shares of the stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of…
1 month ago zacks.com
Theravance Bio (TBPH) Up 0.8% Since Last Earnings Report: Can It Continue?
Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock?
1 month ago defenseworld.net
Theravance Biopharma (NASDAQ:TBPH) Stock Price Crosses Above Fifty Day Moving Average – Time to Sell?
Theravance Biopharma, Inc. (NASDAQ: TBPH - Get Free Report)'s share price crossed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of $16.95 and traded…
2 months ago defenseworld.net
Empowered Funds LLC Purchases Shares of 55,463 Theravance Biopharma, Inc. $TBPH
Empowered Funds LLC acquired a new position in Theravance Biopharma, Inc. (NASDAQ: TBPH) during the undefined quarter, according to the company in its most recent filing with the Securities and…
2 months ago gurufocus.com
TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Theravance Biopharma, Inc. (NASDAQ: TBPH) to Zymeworks Inc. for $17.00 per share.Hal
2 months ago businesswire.com
TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Theravance Biopharma, Inc. (NASDAQ: TBPH) to Zymeworks Inc. for $17.00 per share. Halper Sadeh…
2 months ago zacks.com
TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks
Theravance's Q2 earnings match estimates. Cost cuts and a $929 million Zymeworks deal follow ampreloxetine's discontinuation.
2 months ago prnewswire.com
Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Previously announced acquisition by Zymeworks expected to close in second half of 2026 YUPELRI ® Collaboration Revenue increased 11% year-over-year 1, from $18.7 million to $20.7 million, driven by…
2 months ago defenseworld.net
Theravance Biopharma, Inc. $TBPH Shares Acquired by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP boosted its holdings in Theravance Biopharma, Inc. (NASDAQ: TBPH) by 14.5% in the undefined quarter, according to the company in its most recent 13F filing with the…
3 months ago gurufocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBPH, IRDM, LCII, and PATK
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBPH, IRDM, LCII, and PATK PR Newswire
4 months ago seekingalpha.com
Here's Why Zymeworks Inc. Paid $929M For Theravance Biopharma
Zymeworks Inc. acquires Theravance Biopharma for $929M, pivoting to a hybrid biotech and royalty/cash-flow platform anchored by Yupelri. ZYME gains durable, growing cash flows—$60M annually from…
4 months ago zacks.com
Theravance Stock Down 3% After Zymeworks Announces Buyout
TBPH falls after agreeing to a $929 million all-cash acquisition by Zymeworks, following a strategic review triggered by its failed ampreloxetine program.
4 months ago gurufocus.com
Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders?
Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 29, 2026
4 months ago gurufocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Theravance Biopharma, Inc. (NASDAQ: TBPH)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Theravance Biopharma, Inc. (NASDAQ: TBPH) PR Newswir
4 months ago prnewswire.com
Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
4 months ago benzinga.com
Zymeworks Targets Long-Term Cash Generation Through Theravance Acquisition
Zymeworks will acquire Theravance Biopharma for $929 million, adding YUPELRI cash flows and expanding its portfolio.
-
4 months ago benzinga.com
Theravance Biopharma Discloses Termination Fee Of $32.5M After Acquisition Offer By Zymeworks
The Merger Agreement contains certain customary termination rights for the Company and Parent. Subject to the terms and conditions of the Merger Agreement, the Company or Parent may terminate the…
-
4 months ago benzinga.com
Zymeworks To Acquire Theravance Biopharma At $17 Per Share For Total Cash Consideration Of $929M
Acquisition adds YUPELRI® (revefenacin), the first and only approved nebulized long-acting muscarinic antagonist (LAMA) for the maintenance treatment of COPD to Zymeworks' portfolioAcquisition of…
8 months ago benzinga.com
This Vulcan Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Top Wall Street analysts changed outlook on top names. Check all changes on analyst ratings page. See what analysts think of VMC stock.
8 months ago benzinga.com
Semtech To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
Wall Street analysts changed outlook on top names. For full view of changes, including upgrades/downgrades, see analyst ratings page.
8 months ago benzinga.com
Crude Oil Surges Over 6%; Target Profit Tops Views
US stocks down amid Iran-US conflict. Tehran closed Strait of Hormuz & warned of firing on vessels. Dow down 2.45%, NASDAQ down 2.62%, S&P 500 down 2.34%.
8 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
8 months ago benzinga.com
Dow Dips 900 Points; Best Buy Posts Upbeat Earnings
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 900 points on Tuesday amid the ongoing Iran-U.S. conflict. Iranian state media reported that Tehran has closed the…
9 months ago benzinga.com
Jefferson Capital, Mobix Labs And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Jefferson Capital, Mobix Labs And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
9 months ago benzinga.com
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
10 months ago benzinga.com
mF International, Theravance Biopharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session
mF International, Theravance Biopharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session
10 months ago benzinga.com
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
11 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
11 months ago benzinga.com
Earnings Scheduled For November 10, 2025
Earnings Scheduled For November 10, 2025
1 year ago benzinga.com
PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
1 year ago benzinga.com
Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
Earnings Scheduled For August 12, 2025
Earnings Scheduled For August 12, 2025
-
1 year ago benzinga.com
Earnings Scheduled For February 26, 2025
Earnings Scheduled For February 26, 2025
-
1 year ago benzinga.com
Earnings Scheduled For November 12, 2024
Earnings Scheduled For November 12, 2024
-
2 years ago benzinga.com
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
-
2 years ago benzinga.com
Earnings Scheduled For February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.
-
2 years ago benzinga.com
Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.
-
2 years ago benzinga.com
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 112 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 406 companies made new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 169 companies set new 52-week lows.
-
3 years ago benzinga.com
Earnings Scheduled For August 7, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss at $0.44 per share on revenue of $153.69 million.
-
3 years ago benzinga.com
Earnings Scheduled For May 8, 2023
Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.
-
3 years ago benzinga.com
Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings
Piper Sandler boosted the price target on Target Corporation (NYSE: TGT) from $190 to $200. Target shares fell 13.1% to close at $155.47 on Wednesday.